Stress Response Linked to Brain Cell Death In Early-Onset Dementia

Translate to Spanish or other 102 languages!

New research suggests the body’s inability to turn off the stress response is linked to brain cell death in neurodegenerative diseases. Image for illustration purposes
New research suggests the body’s inability to turn off the stress response is linked to brain cell death in neurodegenerative diseases. Image for illustration purposes
- Advertisement -
  • A new study challenges the concept that protein aggregates in the brain are the direct cause of cell death in neurodegenerative diseases.
  • The researchers noted the culprit is the body’s inability to turn off the stress response in brain cells.
  • The findings highlight the potential for using certain drugs to deactivate the brain’s stress response and maintain the activity of a newly identified protein complex, SIFI.
  • The new insights shift the focus from targeting protein aggregates to managing the stress response mechanism and introduce the potential for new treatment strategies.

Many neurodegenerative conditions, including Alzheimer’s disease (AD) and Parkinson’s disease (PD), have been linked to the buildup of protein aggregates in the brain, leading researchers to believe that these protein clumps are responsible for the death of brain cells.

Follow the link below to reads the rest of the story on Medical News Today:

https://www.medicalnewstoday.com/articles/stress-response-linked-to-brain-cell-death-alzheimers-parkinsons?utm_source=Sailthru%20Email&utm_medium=Email&utm_campaign=MNT%20Daily%20News&utm_content=2024-02-22&apid=&rvid=4ba4ec80177cae00eabc43b8bc6648d598c4a356d104663735777e0a0f8b5c9f

- Advertisement -

Information Source: https://www.medicalnewstoday.com

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

FDA Clears Path for Expanded Testosterone Therapy Options for Men

The U.S. Food and Drug Administration is taking an initial step to advance treatment options for men’s health by encouraging sponsors of approved testosterone replacement therapy (TRT) products to contact FDA for information if they are interested in pursuing a potential new indication for low libido in men with idiopathic hypogonadism (without a known cause).

Study Finds Persistent Barriers to Hormone Therapy for Cervical Cancer Patients

Most oncologists say they would prescribe hormone therapy to cervical cancer patients who experience early menopause from radiation treatment, but barriers are keeping many from doing so in practice, according to a new University of Kentucky Markey Cancer Center study published in JAMA Network Open.

Three Everyday Habits That Could Be Ruining Your Sleep

 If you struggle to get a good night’s sleep, you may want to look at some of your habits – like what time you actually go to bed.

When GLP‑1s Fall Short

Over the last few years, glucagon-like peptide-1 (GLP-1) receptor agonistsTrusted Source have been growing in popularity for not only treating type 2 diabetes but also for weight loss. 
- Advertisement -